Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Jan 28, 2021

SELL
$157.07 - $174.35 $5.78 Million - $6.42 Million
-36,802 Closed
0 $0
Q3 2020

Nov 03, 2020

BUY
$137.1 - $165.37 $928,304 - $1.12 Million
6,771 Added 22.55%
36,802 $6.09 Million
Q2 2020

Aug 04, 2020

BUY
$111.92 - $142.53 $111 - $142
1 Added 0.0%
30,031 $4.12 Million
Q1 2020

May 07, 2020

SELL
$92.66 - $144.94 $713,389 - $1.12 Million
-7,699 Reduced 20.41%
30,030 $3.53 Million
Q4 2019

Jan 21, 2020

SELL
$116.25 - $133.25 $55,218 - $63,293
-475 Reduced 1.24%
37,729 $4.99 Million
Q3 2019

Oct 11, 2019

SELL
$112.57 - $128.43 $1.67 Million - $1.91 Million
-14,850 Reduced 27.99%
38,204 $4.76 Million
Q2 2019

Jul 24, 2019

SELL
$97.98 - $114.28 $117,576 - $137,136
-1,200 Reduced 2.21%
53,054 $6.02 Million
Q1 2019

Apr 23, 2019

BUY
$81.56 - $100.67 $4.42 Million - $5.46 Million
54,254 New
54,254 $5.46 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.8B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Decatur Capital Management, Inc. Portfolio

Follow Decatur Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Decatur Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Decatur Capital Management, Inc. with notifications on news.